title: Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
abstract: OBJECTIVE
  To compare the capacity of the 2004 diagnostic guidelines for hemophagocytic lymphohistiocytosis (HLH-2004) with the capacity of the preliminary diagnostic guidelines for systemic juvenile idiopathic arthritis (JIA)-associated macrophage activation syndrome (MAS) to discriminate MAS complicating systemic JIA from 2 potentially confusable conditions, represented by active systemic JIA without MAS and systemic infection.
  
  
  METHODS
  International pediatric rheumatologists and hemato-oncologists were asked to retrospectively collect clinical information from patients with systemic JIA-associated MAS and confusable conditions. The ability of the guidelines to differentiate MAS from the control diseases was evaluated by calculating the sensitivity and specificity of each set of guidelines and the kappa statistics for concordance with the physician's diagnosis. Owing to the fact that not all patients were assessed for hemophagocytosis on bone marrow aspirates and given the lack of data on natural killer cell activity and soluble CD25 levels, the HLH-2004 guidelines were adapted to enable the diagnosis of MAS when 3 of 5 of the remaining items (3/5-adapted) or 4 of 5 of the remaining items (4/5-adapted) were present.
  
  
  RESULTS
  The study sample included 362 patients with systemic JIA and MAS, 404 patients with active systemic JIA without MAS, and 345 patients with systemic infection. The best capacity to differentiate MAS from systemic JIA without MAS was found when the preliminary MAS guidelines were applied. The 3/5-adapted HLH-2004 guidelines performed better than the 4/5-adapted guidelines in distinguishing MAS from active systemic JIA without MAS. The 3/5-adapted HLH-2004 guidelines and the preliminary MAS guidelines with the addition of ferritin levels ≥500 ng/ml discriminated best between MAS and systemic infections.
  
  
  CONCLUSIONS
  The preliminary MAS guidelines showed the strongest ability to identify MAS in systemic JIA. The addition of hyperferritinemia enhanced their capacity to differentiate MAS from systemic infections. The HLH-2004 guidelines are likely not appropriate for identification of MAS in children with systemic JIA.
authors.affiliation: Università degli Studi di Genova, Genoa, Italy.
authors.forename: Sergio
authors.initials: S
authors.lastname: Davì
authors.forename: Francesca
authors.initials: F
authors.lastname: Minoia
authors.forename: Angela
authors.initials: A
authors.lastname: Pistorio
authors.forename: AnnaCarin
authors.initials: A
authors.lastname: Horne
authors.forename: Alessandro
authors.initials: A
authors.lastname: Consolaro
authors.forename: Silvia
authors.initials: S
authors.lastname: Rosina
authors.forename: Francesca
authors.initials: F
authors.lastname: Bovis
authors.forename: Rolando
authors.initials: R
authors.lastname: Cimaz
authors.forename: Maria Luz
authors.initials: ML
authors.lastname: Gamir
authors.forename: Norman T
authors.initials: NT
authors.lastname: Ilowite
authors.forename: Isabelle
authors.initials: I
authors.lastname: Kone-Paut
authors.forename: Sheila Knupp
authors.initials: SK
authors.lastname: Feitosa de Oliveira
authors.forename: Deborah
authors.initials: D
authors.lastname: McCurdy
authors.forename: Clovis Artur
authors.initials: CA
authors.lastname: Silva
authors.forename: Flavio
authors.initials: F
authors.lastname: Sztajnbok
authors.forename: Elena
authors.initials: E
authors.lastname: Tsitsami
authors.forename: Erbil
authors.initials: E
authors.lastname: Unsal
authors.forename: Jennifer E
authors.initials: JE
authors.lastname: Weiss
authors.forename: Nico
authors.initials: N
authors.lastname: Wulffraat
authors.forename: Mario
authors.initials: M
authors.lastname: Abinun
authors.forename: Amita
authors.initials: A
authors.lastname: Aggarwal
authors.forename: Maria Teresa
authors.initials: MT
authors.lastname: Apaz
authors.forename: Itziar
authors.initials: I
authors.lastname: Astigarraga
authors.forename: Fabrizia
authors.initials: F
authors.lastname: Corona
authors.forename: Ruben
authors.initials: R
authors.lastname: Cuttica
authors.forename: Gianfranco
authors.initials: G
authors.lastname: D'Angelo
authors.forename: Eli M
authors.initials: EM
authors.lastname: Eisenstein
authors.forename: Soad
authors.initials: S
authors.lastname: Hashad
authors.forename: Loredana
authors.initials: L
authors.lastname: Lepore
authors.forename: Velma
authors.initials: V
authors.lastname: Mulaosmanovic
authors.forename: Susan
authors.initials: S
authors.lastname: Nielsen
authors.forename: Sampath
authors.initials: S
authors.lastname: Prahalad
authors.forename: Donato
authors.initials: D
authors.lastname: Rigante
authors.forename: Valda
authors.initials: V
authors.lastname: Stanevicha
authors.forename: Gary
authors.initials: G
authors.lastname: Sterba
authors.forename: Gordana
authors.initials: G
authors.lastname: Susic
authors.forename: Syuji
authors.initials: S
authors.lastname: Takei
authors.forename: Ralf
authors.initials: R
authors.lastname: Trauzeddel
authors.forename: Mabruka
authors.initials: M
authors.lastname: Zletni
authors.forename: Nicolino
authors.initials: N
authors.lastname: Ruperto
authors.forename: Alberto
authors.initials: A
authors.lastname: Martini
authors.forename: Randy Q
authors.initials: RQ
authors.lastname: Cron
authors.forename: Angelo
authors.initials: A
authors.lastname: Ravelli
mesh_terms: D001171:Arthritis, Juvenile / Q000150:complications*; D002648:Child; D002675:Child, Preschool; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007223:Infant; D051359:Lymphohistiocytosis, Hemophagocytic / Q000175:diagnosis*; D055501:Macrophage Activation Syndrome / Q000150:complications / Q000175:diagnosis*; D008297:Male; D017410:Practice Guidelines as Topic; D012189:Retrospective Studies